000 01625 a2200493 4500
005 20250516115858.0
264 0 _c20130328
008 201303s 0 0 eng d
022 _a2589-0646
024 7 _a10.5144/1658-3876.2012.169
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalter, Claudia Ulrike
245 0 0 _aThe t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities.
_h[electronic resource]
260 _bHematology/oncology and stem cell therapy
_c2012
300 _a169-70 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChromosomes, Human, Pair 11
650 0 4 _aChromosomes, Human, Pair 9
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aStem Cell Transplantation
650 0 4 _aSurvival Rate
650 0 4 _aTranslocation, Genetic
650 0 4 _aYoung Adult
700 1 _aMohareb, Fahad Al
700 1 _aChaudhri, Naeem
700 1 _aAlsharif, Fahad
700 1 _aZahrani, Hazzaa Al
700 1 _aMohamed, Said
700 1 _aRasheed, Walid
700 1 _aSaleh, Abu Jafar
700 1 _aChebbo, Wahiba
700 1 _aEl Gohary, Ghada
700 1 _aAljurf, Mahmoud
700 1 _aAlbitar, Maher
773 0 _tHematology/oncology and stem cell therapy
_gvol. 5
_gno. 3
_gp. 169-70
856 4 0 _uhttps://doi.org/10.5144/1658-3876.2012.169
_zAvailable from publisher's website
999 _c22210606
_d22210606